The report determined that 4.9 million people whose health insurance covered Zepbound last year actually lost coverage of the drug in 2025
While both offer weight-loss benefits, key differences exist: Mechanism of Action: Tirzepatide targets both GLP-1 and GIP receptors
Richard Bloomer, PhD, academic dean, research scientist, and dietary supplement expert
Can I meal prep while taking GLP-1 medications
Preclinical research has also observed downregulation of pro-inflammatory cytokines including TNF-, IL-6, and IL-1, alongside modulation of NF-B signalling pathways positioning GHK-Cu as a subject of interest in inflammatory resolution research
These include metformin, GLP-1 receptor agonists, GIP/GLP-1 therapy, SGLT2 inhibitors, DPP-4 inhibitors, insulin, and combination products